$NVS

AI Analysis

Generated on May 11, 2026

AI Score
74/ 100
Hold$NVS

Novartis AG

$NVSNYSEHealthcareMega-Cap

Novartis develops and manufactures innovative medicines across cardiovascular, immunology, neuroscience, and oncology.

Market Cap
$205.0B
Revenue (TTM)
$47.0B
+8.0%
Net Income (TTM)
$11.0B
+12.0%
EPS (TTM)
$5.30
P/E Ratio
18.0
Dividend Yield
3.0%
52-Week Range
$85-$115
Beta
0.42
Dimension Scores
Fundamental
76
Technical
68
Sentiment
72
Risk / Reward
76
Momentum
66
FundTechSentRiskMome
Financial Health
Profitability
81strong
Growth
69moderate
Liquidity
84strong
Solvency
78strong
Efficiency
74strong

Valuation, technical analysis, investment thesis, risk assessment and more for $NVS

Free · No credit card required

Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.

Explore more

Analyze any stock with AI

Get a structured equity research report covering fundamentals, technicals, sentiment, risk, and investment thesis — in about 60 seconds.